Financhill
Back

Alnylam Pharmaceuticals Vs. Novo Nordisk AS Industry Stock Comparison

Sell
28

ALNY
Alnylam Pharmaceuticals

Last Price:
$234.30
Seasonality Move:
1.18%
Sell
26

NVO
Novo Nordisk AS

Last Price:
$87.66
Seasonality Move:
6.4%
Sell
28
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $234.28. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $87.65. The Score for NVO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $234.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight buying pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $87.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight selling pressure.

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.64 Sell
Relative Strength Index (14 RSI): 34.99 Sell
Chaikin Money Flow: 88822 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (238.52 - 253.26) Sell
Bollinger Bands (100): (247.42 - 280.76) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.01 Sell
Relative Strength Index (14 RSI): 30.1 Sell
Chaikin Money Flow: -992739 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (90.25 - 110.97) Sell
Bollinger Bands (100): (101.58 - 130.52) Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 238.15 Sell
20-day SMA: 244.04 Sell
50-day SMA: 255.8 Sell
200-day SMA: 224.04 Buy
8-day EMA: 237.45 Sell
20-day EMA: 242.71 Sell
50-day EMA: 251.44 Sell
200-day EMA: 234.53 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 87.25 Buy
20-day SMA: 98.78 Sell
50-day SMA: 104.32 Sell
200-day SMA: 124.42 Sell
8-day EMA: 89.14 Sell
20-day EMA: 95.42 Sell
50-day EMA: 103.78 Sell
200-day EMA: 115.72 Sell

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $4.76 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $0.66 per share.

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):